Journal Mobile Options

Vol. 80, No. 5-6, 2011

Issue release date: August 2011

Select / Unselect all
Clinical Study
289

Retrospective Analysis of Adjuvant Intraperitoneal Chemotherapy Effect Prognosis of Resectable Gastric Cancer

Shi C. · Yang B. · Chen Q. · Yang J. · Fan N.
Oncology 2011;80:289–295 (DOI:10.1159/000329075)
296

Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy

Tamura S. · Fujitani K. · Kimura Y. · Tsuji T. · Matsuyama J. · Iijima S. · Imamura H. · Inoue K. · Kobayashi K. · Kurokawa Y. · Furukawa H. · the Osaka Gastrointestinal Cancer Chemotherapy Study Group
Oncology 2011;80:296–300 (DOI:10.1159/000329090)
301

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Assaf E. · Verlinde-Carvalho M. · Delbaldo C. · Grenier J. · Sellam Z. · Pouessel D. · Bouaita L. · Baumgaertner I. · Sobhani I. · Tayar C. · Paul M. · Culine S.
Oncology 2011;80:301–306 (DOI:10.1159/000329803)
307

Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus

Yamasaki M. · Miyata H. · Tanaka K. · Shiraishi O. · Motoori M. · Peng Y.F. · Yasuda T. · Yano M. · Shiozaki H. · Mori M. · Doki Y.
Oncology 2011;80:307–313 (DOI:10.1159/000329806)
Review
314

Safety of Bevacizumab in Patients with Metastatic Breast Cancer

Hamilton E.P. · Blackwell K.L.
Oncology 2011;80:314–325 (DOI:10.1159/000328757)
Short Communication
326

Additional Lesions Detected in Therapeutic Scans with 177Lu-DOTATATE Reflect Higher Affinity of 177Lu-DOTATATE for Somatostatin Receptors

Mirzaei S. · Bastati B. · Lipp R.W. · Knoll P. · Zojer N. · Ludwig H.
Oncology 2011;80:326–329 (DOI:10.1159/000329808)
330

Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma

Schäfer N. · Tichy J. · Thanendrarajan S. · Kim Y. · Stuplich M. · Mack F. · Rieger J. · Simon M. · Scheffler B. · Boström J. · Steinbach J.P. · Herrlinger U. · Glas M.
Oncology 2011;80:330–332 (DOI:10.1159/000330358)
Clinical Translational Research
333

The Diagnostic Value of Cytokeratin 5/6, 14, 17, and 18 Expression in Human Non-Small Cell Lung Cancer

Chen Y. · Cui T. · Yang L. · Mireskandari M. · Knoesel T. · Zhang Q. · Pacyna-Gengelbach M. · Petersen I.
Oncology 2011;80:333–340 (DOI:10.1159/000329098)
Clinical Study
341

Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer

Vargo J.A. · Beriwal S. · Ahrendt G.M. · Soran A. · Johnson R.R. · McGuire K. · Bhargava R.
Oncology 2011;80:341–349 (DOI:10.1159/000330203)
350

Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach

Tassinari D. · Sartori S. · Papi M. · Drudi F. · Castellani C. · Carloni F. · Tombesi P. · Lazzari-Agli L.
Oncology 2011;80:350–358 (DOI:10.1159/000328781)
359

Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer

Amarantidis K. · Xenidis N. · Chelis L. · Chamalidou E. · Dimopoulos P. · Michailidis P. · Tentes A. · Deftereos S. · Karanikas M. · Karayiannakis A. · Kakolyris S.
Oncology 2011;80:359–365 (DOI:10.1159/000330199)
366

Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients

Kanda T. · Imazeki F. · Mikami S. · Kato K. · Shimada N. · Yonemitsu Y. · Miyauchi T. · Arai M. · Fujiwara K. · Tsubota A. · Takada N. · Nishino T. · Takashi M. · Sugiura N. · Kimura M. · Fukai K. · Yokosuka O.
Oncology 2011;80:366–372 (DOI:10.1159/000330549)
373

I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score

Kaseb A.O. · Abbruzzese J.L. · Vauthey J.-N. · Aloia T.A. · Abdalla E.K. · Hassan M.M. · Lin E. · Xiao L. · El-Deeb A.S. · Rashid A. · Morris J.S.
Oncology 2011;80:373–381 (DOI:10.1159/000329040)
Free Access
Clinical Translational Research
382

Enhanced Nitrosative and Oxidative Stress with Decreased Total Antioxidant Capacity in Patients with Oral Precancer and Oral Squamous Cell Carcinoma

Korde S.D. · Basak A. · Chaudhary M. · Goyal M. · Vagga A.
Oncology 2011;80:382–389 (DOI:10.1159/000329811)
Clinical Study
390

Phase II Study on Weekly Bolus Topotecan in Advanced or Recurrent Cervical Cancer

Lorusso D. · Mainenti S. · Pietragalla A. · Fusco E. · Malaguti P. · Masciullo V. · Scambia G.
Oncology 2011;80:390–394 (DOI:10.1159/000330537)
395

Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles

Kim H.S. · Hong M.H. · Kim K. · Shin S.-J. · Ahn J.-B. · Jeung H.C. · Chung H.C. · Koh Y. · Lee S.-H. · Bang Y.-J. · Rha S.Y.
Oncology 2011;80:395–405 (DOI:10.1159/000330361)
Clinical Translational Research
406

Identification by Differential Tissue Proteome Analysis of Talin-1 as a Novel Molecular Marker of Progression of Hepatocellular Carcinoma

Kanamori H. · Kawakami T. · Effendi K. · Yamazaki K. · Mori T. · Ebinuma H. · Masugi Y. · Du W. · Nagasaka K. · Ogiwara A. · Kyono Y. · Tanabe M. · Saito H. · Hibi T. · Sakamoto M.
Oncology 2011;80:406–415 (DOI:10.1159/000330734)
Further Section
416

Acknowledgement to the Reviewers

Oncology 2011;80:416–418 (DOI:10.1159/000331600)
Free Access
I

Contents Vol. 80, 2011

Oncology 2011;80:I–IV (DOI:10.1159/000331601)
Free Access